Cargando…

Antidepressant- and anxiolytic-like effects of the phosphodiesterase-4 (PDE4) inhibitor rolipram on behavior depend on cyclic AMP-response element binding protein (CREB)-mediated neurogenesis in the hippocampus

Inhibition of phosphodiesterase-4 (PDE4), an enzyme that catalyzes the hydrolysis of cyclic AMP (cAMP), increases phosphorylation of cAMP-response element binding protein (pCREB) and hippocampal neurogenesis, and produces antidepressant-like effects on behavior; however, causal links among these hav...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Yun-Feng, Huang, Ying, Amsdell, Simon L., Xiao, Lan, O'Donnell, James M., Zhang, Han-Ting
Formato:	Texto
Lenguaje:	English
Publicado:	2009
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2743762/ https://www.ncbi.nlm.nih.gov/pubmed/19516250 http://dx.doi.org/10.1038/npp.2009.66

Ejemplares similares

Small-molecule allosteric activators of PDE4 long form cyclic AMP phosphodiesterases
por: Omar, Faisa, et al.
Publicado: (2019)

Rolipram, a Phosphodiesterase 4 Inhibitor, Stimulates Inducible cAMP Early Repressor Expression in Osteoblasts
por: Cho, Eun Sook, et al.
Publicado: (2005)

The protective effect of the PDE-4 inhibitor rolipram on intracerebral haemorrhage is associated with the cAMP/AMPK/SIRT1 pathway
por: Dong, Xiao-Liu, et al.
Publicado: (2021)

Rescue of Cyclic AMP Mediated Long Term Potentiation Impairment in the Hippocampus of Mecp2 Knockout (Mecp2(-/y)) Mice by Rolipram
por: Balakrishnan, Saju, et al.
Publicado: (2016)

Phosphodiesterase Type 4 Inhibitor Rolipram Improves Survival of Spiral Ganglion Neurons In Vitro
por: Kranz, Katharina, et al.
Publicado: (2014)

Impact of phosphodiesterases PDE3 and PDE4 on 5-hydroxytryptamine receptor4-mediated increase of cAMP in human atrial fibrillation
por: Dolce, Bernardo, et al.
Publicado: (2020)

Evaluation of Antidepressant and Anxiolytic Activity of Phosphodiesterase 3 Inhibitor - Cilostazol
por: Patel, Dipesh S., et al.
Publicado: (2012)

Effect of phosphodiesterase‐4 inhibitor rolipram on colonic hypermotility in water avoidance stress rat model
por: Yuan, FangTing, et al.
Publicado: (2022)

Pharmacophore Modeling and Virtual Screening for the Discovery of New type 4 cAMP Phosphodiesterase (PDE4) Inhibitors
por: Niu, Miaomiao, et al.
Publicado: (2013)

The PDE4 inhibitor rolipram reverses object memory impairment induced by acute tryptophan depletion in the rat
por: Rutten, K., et al.
Publicado: (2007)

PDE4B Is a Homeostatic Regulator of Cyclic AMP in Dendritic Cells
por: Chinn, Amy M., et al.
Publicado: (2022)

Phosphodiesterase (PDE) III inhibitor, Cilostazol, improved memory impairment in aluminum chloride-treated rats: modulation of cAMP/CREB pathway
por: Khalifa, Mona, et al.
Publicado: (2022)

The conserved protective cyclic AMP-phosphodiesterase function PDE4B is expressed in the adenoma and adjacent normal colonic epithelium of mammals and silenced in colorectal cancer
por: Pleiman, Jennifer K., et al.
Publicado: (2018)

cAMP/PKA/CREB/GLT1 signaling involved in the antidepressant-like effects of phosphodiesterase 4D inhibitor (GEBR-7b) in rats
por: Liu, Xu, et al.
Publicado: (2016)

Rolipram, a PDE4 Inhibitor, Enhances the Inotropic Effect of Rat Heart by Activating SERCA2a
por: Huang, Huili, et al.
Publicado: (2019)

Rolipram Prevents the Formation of Abdominal Aortic Aneurysm (AAA) in Mice: PDE4B as a Target in AAA
por: Varona, Saray, et al.
Publicado: (2021)

Correction to: Phosphodiesterase (PDE) III inhibitor, Cilostazol, improved memory impairment in aluminum chloride-treated rats: modulation of cAMP/CREB pathway
por: Khalifa, Mona, et al.
Publicado: (2022)

Phenotypic, chemical and functional characterization of cyclic nucleotide phosphodiesterase 4 (PDE4) as a potential anthelmintic drug target
por: Long, Thavy, et al.
Publicado: (2017)

MiR-139-5p has an antidepressant-like effect by targeting phosphodiesterase 4D to activate the cAMP/PKA/CREB signaling pathway
por: Huang, Peng, et al.
Publicado: (2021)

Dominant-Negative Attenuation of cAMP-Selective Phosphodiesterase PDE4D Action Affects Learning and Behavior
por: Bolger, Graeme B., et al.
Publicado: (2020)

The Complexity and Multiplicity of the Specific cAMP Phosphodiesterase Family: PDE4, Open New Adapted Therapeutic Approaches
por: Lugnier, Claire
Publicado: (2022)

Phosphodiesterase (PDE)-4 Inhibitors and COPD Correlation with Cancer
por: Organtzis, John, et al.
Publicado: (2014)

Chemical informatics uncovers a new role for moexipril as a novel inhibitor of cAMP phosphodiesterase-4 (PDE4)
por: Cameron, Ryan T., et al.
Publicado: (2013)

Apremilast, a novel phosphodiesterase 4 (PDE4) inhibitor, regulates inflammation through multiple cAMP downstream effectors
por: Perez-Aso, Miguel, et al.
Publicado: (2015)

Quantification of human brain PDE4 occupancy by GSK356278: A [(11)C](R)-rolipram PET study
por: van der Aart, Jasper, et al.
Publicado: (2017)

The Biological Effects of Forsythia Leaves Containing the Cyclic AMP Phosphodiesterase 4 Inhibitor Phillyrin
por: Nishibe, Sansei, et al.
Publicado: (2021)

Rolipram: Eotaxin and phosphodiesterase IV inhibitor versus bronchial hyper-reactivity response
por: Khan, Hamza Hassan, et al.
Publicado: (2015)

Inhaled Phosphodiesterase 4 (PDE4) Inhibitors for Inflammatory Respiratory Diseases
por: Phillips, Jonathan E.
Publicado: (2020)

Cyclic AMP compartments and signaling specificity: Role of cyclic nucleotide phosphodiesterases
por: Conti, Marco, et al.
Publicado: (2014)

Calcium/Calpain mediated regulation of cyclic nucleotide phosphodiesterases, PDE3A and PDE5, in human platelets
por: Rybalkina, Irina G, et al.
Publicado: (2011)

PDE4-Mediated cAMP Signalling
por: Fertig, Bracy A., et al.
Publicado: (2018)

Type-4 Phosphodiesterase (PDE4) Blockade Reduces NETosis in Cystic Fibrosis
por: Totani, Licia, et al.
Publicado: (2021)

Dimerization of cAMP phosphodiesterase-4 (PDE4) in living cells requires interfaces located in both the UCR1 and catalytic unit domains
por: Bolger, Graeme B., et al.
Publicado: (2015)

Selective PDE inhibitors rolipram and sildenafil improve object retrieval performance in adult cynomolgus macaques
por: Rutten, K., et al.
Publicado: (2007)

Phosphodiesterase 1b (PDE1B) Regulates Spatial and Contextual Memory in Hippocampus
por: McQuown, Susan, et al.
Publicado: (2019)

Phosphodiesterase-4 inhibition with rolipram attenuates hepatocellular injury in hyperinflammation in vivo and in vitro without influencing inflammation and HO-1 expression
por: Wollborn, Jakob, et al.
Publicado: (2015)

S 47445 Produces Antidepressant- and Anxiolytic-Like Effects through Neurogenesis Dependent and Independent Mechanisms
por: Mendez-David, Indira, et al.
Publicado: (2017)

Bacterial Cyclic AMP-Phosphodiesterase Activity Coordinates Biofilm Formation
por: Kalivoda, Eric J., et al.
Publicado: (2013)

The Therapeutic Profile of Rolipram, PDE Target and Mechanism of Action as a Neuroprotectant following Spinal Cord Injury
por: Schaal, Sandra Marie, et al.
Publicado: (2012)

Epac and the high affinity rolipram binding conformer of PDE4 modulate neurite outgrowth and myelination using an in vitro spinal cord injury model
por: Boomkamp, S D, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_i5dm32p3mktdm0k4qp9tdqqvbu